Bank of Montreal
IRD

Bank of Montreal’s Opus Genetics IRD Stock Holding History

Bank of Montreal’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,600
Closed -$68K – 4513
2022
Q1 		$68K Buy
+15,600
New +$53.4K ﹤0.01% 3740
2019
Q3 		– Sell
-177
Closed -$4K – 5032
2019
Q2 		$4K Buy
177
+31
+21% +$701 ﹤0.01% 4704
2019
Q1 		$43K Buy
+146
New +$4.84K ﹤0.01% 3398
2018
Q4 		– Sell
-104
Closed -$9K – 4887
2018
Q3 		$9K Hold
104
– – ﹤0.01% 3960
2018
Q2 		$7K Hold
104
– – ﹤0.01% 4062
2018
Q1 		$8K Hold
104
– – ﹤0.01% 3837
2017
Q4 		$10K Buy
+104
New +$10.6K ﹤0.01% 3782

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's IRD Position: Q2 2022 in Review

Bank of Montreal sold out of Opus Genetics (IRD) in Q2 2022, closing a stake of 15,600 shares — an estimated $68K sold.

Bank of Montreal first reported a position in IRD in Q4 2017 and held it in 7 quarters. The position peaked at $68K in Q1 2022. 38 funds tracked by Wall St. Rank hold IRD as of Q2 2022.

  • Bank of Montreal reported no remaining Opus Genetics position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 15,600 Opus Genetics shares in Q2 2022, an estimated $68K.
  • Bank of Montreal first reported a position in Opus Genetics in Q4 2017 and held it in 7 quarters.
  • Bank of Montreal's Opus Genetics position peaked at $68K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.